Possible involvement of RasGRP4 in leukemogenesis (Q33427443)

26 July 2017

Possible involvement of RasGRP4 in leukemogenesis (English)

1 reference

26 July 2017

Yukiko Komeno

3

1 reference

ORCID Public Data File 2021

author name string

Naoko Watanabe-Okochi

1

1 reference

26 July 2017

Toshihiko Oki

2

1 reference

26 July 2017

Naoko Kato

4

1 reference

26 July 2017

Koichiro Yuji

5

1 reference

26 July 2017

Ryoichi Ono

6

1 reference

26 July 2017

Yuka Harada

7

1 reference

26 July 2017

Hironori Harada

8

1 reference

26 July 2017

Yasuhide Hayashi

9

1 reference

26 July 2017

Hideaki Nakajima

10

1 reference

26 July 2017

Tetsuya Nosaka

11

1 reference

26 July 2017

Jiro Kitaura

12

1 reference

26 July 2017

Toshio Kitamura

13

1 reference

26 July 2017

7 April 2009

1 reference

International Journal of Hematology

26 July 2017

1 reference

26 July 2017

89

1 reference

26 July 2017

4

1 reference

26 July 2017

470-481

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-009-0299-0

26 July 2017

0 references

cites work

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

1 reference

12 December 2020

RasGRP4 is a novel Ras activator isolated from acute myeloid leukemia

1 reference

12 December 2020

Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis

1 reference

12 December 2020

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

1 reference

12 December 2020

Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations

1 reference

12 December 2020

Incidence and prognostic impact of c-Kit, FLT3, and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML).

1 reference

12 December 2020

KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group

1 reference

12 December 2020

Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia

1 reference

12 December 2020

Variable prognostic value of FLT3 internal tandem duplications in patients with de novo AML and a normal karyotype, t(15;17), t(8;21) or inv(16).

1 reference

12 December 2020

K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.

1 reference

12 December 2020

Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias

1 reference

12 December 2020

Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia

1 reference

12 December 2020

PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model

1 reference

12 December 2020

Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA

1 reference

12 December 2020

Haploinsufficiency of Runx1/AML1 promotes myeloid features and leukaemogenesis in BXH2 mice.

1 reference

12 December 2020

New experimental approaches in retrovirus-mediated expression screening

1 reference

12 December 2020

AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression

1 reference

12 December 2020

FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia.

1 reference

12 December 2020

C-kit mutations in core binding factor leukemias

1 reference

12 December 2020

Efficient screening of retroviral cDNA expression libraries

1 reference

12 December 2020

Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics

1 reference

12 December 2020

AML1 mutations induced MDS and MDS/AML in a mouse BMT model

1 reference

12 December 2020

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

1 reference

12 December 2020

AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.

1 reference

12 December 2020

Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol

1 reference

12 December 2020

Direct evidence for cooperating genetic events in the leukemic transformation of normal human hematopoietic cells.

1 reference

12 December 2020

Role of FLT3 in leukemia

1 reference

12 December 2020

Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like disease.

1 reference

12 December 2020

Mutations of genes in the receptor tyrosine kinase (RTK)/RAS-BRAF signal transduction pathway in therapy-related myelodysplasia and acute myeloid leukemia

1 reference

12 December 2020

High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia

1 reference

12 December 2020

Dual mutations in the AML1 and FLT3 genes are associated with leukemogenesis in acute myeloblastic leukemia of the M0 subtype

1 reference

12 December 2020

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

1 reference

12 December 2020

Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia

1 reference

12 December 2020

A novel gene, FGA7, is fused to RUNX1/AML1 in a t(4;21)(q28;q22) in a patient with T-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group

1 reference

12 December 2020

KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication

1 reference

12 December 2020

Functional analysis of activating receptor LMIR4 as a counterpart of inhibitory receptor LMIR3.

1 reference

12 December 2020

RasGRP4, a new mast cell-restricted Ras guanine nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Identification of defective variants of this signaling protein in asthma, mastocytosis, and mast cell leukemia patients and

1 reference

12 December 2020

The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice

1 reference

12 December 2020

10.1007/S12185-009-0299-0

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference